At SRM Institute of Science and Technology, we offer interdisciplinary programs in areas like Medical Engineering, ECE with ...

Discover a dual-action formula that fades dark spots and reduces under-eye bags. Learn how this innovative treatment delivers brighter.

Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first ...

AI is reshaping labs and Clever Culture’s tech is gaining Big Pharma attention as diagnostics and cleanrooms go digital.

The global bullous keratopathy market is forecasted to grow at a compounded annual growth rate (CAGR) of 4.3% from 2023 to 2033, is anticipated, with an anticipated closing value of USD 650 Million by ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Iolyx Therapeutics, a clinical-stage biotechnology company focused on the development of therapeutics at the intersection of ocular inflammation and autoimmunity, today announced top-line data from ...

Further, Editas Medicine has decreased expenses and costs thanks to discontinuing the development of reni-cel and laying off ...

Durham-based Atsena Therapeutics has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for ATSN-201, its gene therapy product for the ...

Hot on the heels of a $150 million fundraise, Atsena Therapeutics is back with early-stage data for the company’s eye disease ...

Krishnan, Chairman and CEO of Krystal Biotech. “With today’s announcement ... of our registrational study in DEB patients with eye lesions, and upcoming molecular readouts for our rare ...